For head and neck cancers with high EGFR expression at the same time, this discovery can reveal the mechanism of cetuximab resistance in patients with head and neck cancer and the clinical application of new therapeutic targets was of great significance. The gene discussed is EGFR; the disease is head and neck cancer.